Profil
Alan O’Connell is a Partner at Seroba.
He has a background in product and business development in the pharmaceutical and biotechnology industries.
Prior to joining the firm in 2003, Alan worked in a variety of product and business development roles at Elan Corporation (Dublin), American Biogenetic Sciences, Inc. (New York), and he also spent time in the Pharmacovigilance section at the Medicines and Healthcare Products Regulatory Agency (London).
His previous venture capital experience was gained at Estée Lauder Investments (New York) and he still sits on the scientific advisory board of the Lauder funded Alzheimer’s Drug Discovery Foundation.
Alan graduated with a Ph.D.
(neuropharmacology) from the National University of Ireland, Galway in 1994 and has a Master’s degree in pharmacology from the University of London (1990).
He carried out post-doctoral neuroscience research at University College, Dublin and has published in several scientific journals.
Alan sits on the boards of: Ario Pharma; Crescent Diagnostics and Shorla Pharma.
He previously sat on the boards of Fusion Pharmaceuticals (NASDAQ: FUSN), Prexton Therapeutics (acquired by Lundbeck), Veryan Medical (acquired by Otsuka Medical) and Xention (exited via pharma partnerships).
Postes actifs de Alan William O'Connell
| Sociétés | Poste | Début |
|---|---|---|
Crescent Diagnostics Ltd.
Crescent Diagnostics Ltd. Medical/Nursing ServicesHealth Services Operates as a medical diagnostics company | Directeur/Membre du Conseil | 18/09/2006 |
Veryan Medical Ltd.
Veryan Medical Ltd. BiotechnologyHealth Technology Develops and commercializes novel vascular stent technology | Directeur/Membre du Conseil | 08/06/2010 |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Directeur/Membre du Conseil | - |
Seroba BioVentures Ltd.
Seroba BioVentures Ltd. Investment ManagersFinance Seroba BioVentures invests in biotech and medtech companies located in Europe. The firm provides financing for early stage capital requirements. | Private Equity Investor | 01/01/2003 |
Prexton Therapeutics SA
Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Provides novel therapeutic compounds for treatment of Parkinson disease and other brain disorders | Directeur/Membre du Conseil | - |
Anciens postes connus de Alan William O'Connell
| Sociétés | Poste | Fin |
|---|---|---|
| FUSN PHAR | Directeur/Membre du Conseil | - |
| ESTEE LAUDER | Corporate Officer/Principal | - |
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Develops medical therapy for the treatment of heart failure | Directeur/Membre du Conseil | - |
PrecisionBiotics Group Ltd.
PrecisionBiotics Group Ltd. Pharmaceuticals: GenericHealth Technology Operates as a healthcare company | Directeur/Membre du Conseil | - |
| ░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Alan William O'Connell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
QHSLab, Inc.
QHSLab, Inc. Financial ConglomeratesFinance Develops testing medical devices | Finance |
The Estée Lauder Companies, Inc.
The Estée Lauder Companies, Inc. Household/Personal CareConsumer Non-Durables Manufactures and distributes skin care, makeup, fragrance & hair care products | Consumer Non-Durables |
PrecisionBiotics Group Ltd.
PrecisionBiotics Group Ltd. Pharmaceuticals: GenericHealth Technology Operates as a healthcare company | Health Technology |
Xention Pharma Ltd.
Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops and researches drugs | Health Technology |
University of London
University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National University of Ireland
National University of Ireland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kernel Management Partners Ltd.
Kernel Management Partners Ltd. Investment ManagersFinance Kernel Capital invests in companies located in Ireland. The firm focuses on sectors such as software & web communications, telecoms, networks, chip, sensors & engineering. It participates in seed and early stage capital transactions with an investment size of EUR 0.5 - 2 million and also acts as lead & Co-investor. | Finance |
Biosensia Ltd.
Biosensia Ltd. Packaged SoftwareTechnology Services Develops multiplexing point of care in vitro diagnostics platform | Technology Services |
Diabetica Ltd.
Diabetica Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs to treat diabetes | Health Technology |
Veryan Medical Ltd.
Veryan Medical Ltd. BiotechnologyHealth Technology Develops and commercializes novel vascular stent technology | Health Technology |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
Crescent Diagnostics Ltd.
Crescent Diagnostics Ltd. Medical/Nursing ServicesHealth Services Operates as a medical diagnostics company | Health Services |
Medicines & Healthcare Products Regulatory Agency
Medicines & Healthcare Products Regulatory Agency General GovernmentGovernment Regulates medicines, medical devices and equipment of healthcare to safeguard the public health | Government |
ario pharma Ltd.
ario pharma Ltd. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of respiratory indications | Health Technology |
Seroba BioVentures Ltd.
Seroba BioVentures Ltd. Investment ManagersFinance Seroba BioVentures invests in biotech and medtech companies located in Europe. The firm provides financing for early stage capital requirements. | Finance |
Prexton Therapeutics SA
Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Provides novel therapeutic compounds for treatment of Parkinson disease and other brain disorders | Health Technology |
Heart Metabolics Ltd.
Heart Metabolics Ltd. BiotechnologyHealth Technology Develops medical therapy for the treatment of heart failure | Health Technology |
Fusion Pharmaceuticals, Inc.
Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
















